European Companies Search Engine
Managing Director: Ralf Göddertz · No longer Managing Director: Katja Gogalla, Randi Mette Selnes · ppa (3) · Address · Name: Daiichi Sankyo Oncology Europe GmbH · Company statute · Corporate Purpose Hrb 19 May 2017 German Trade Register Announcements, Germany (18/05/2017)
Overview
Text
HRB 231622: Blitz 17-59 GmbH, Munich,
Unnamed street ??, 80339 München, Germany
. The shareholders' meeting of May 10, 2017 decided to amend Section 1 (company) 4 (object of the company) 6 (management), 7 (representation) of the Articles of Association. New company: Daiichi Sankyo Oncology Europe GmbH. Business address:
Unnamed street ??, 81379 München, Germany
. New business objective: research and development, research and development services; Manufacture, distribution, trade, marketing and distribution services, import and export, licensing and similar activities of pharmaceutical, chemical, biochemical, medical and veterinary, biological, hygienic, cosmetic and similar products and equipment, including medical aids, with a focus on oncology and business activities in comparable business areas. Further services in the field of manufacturing pharmaceutical products. Retired: Managing Director: Gogalla, Katja, Munich, *??.??.????; Selnes, Randi Mette, Munich, *??.??.????. Appointed: Managing Director: Göddertz, Ralf, Munich, *??.??.????. Total prokura together with a managing director or other authorized representative: ????????, ?????? ?????, Holzkirchen, *??.??.????; Hope, Andrew, Feldafing, *??.??.????; ???????, ?????, Reichersbeuern, *??.??.????.
This filing was translated from German to English. The filing refers to a past date, and does not necessarily reflect the current state. The latest known state is available on the following page: Daiichi Sankyo Oncology Europe GmbH, Munich, Germany.
